title: Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
authors.affiliation: Division of Endocrinology, Diabetes, and Metabolism, Diabetes-Endocrinology Center of Western New York, State University of New York at Buffalo, and Kaleida Health, Buffalo, NY 14209, USA. pdandona@kaleidahealth.org
authors.forename: Paresh
authors.initials: P
authors.lastname: Dandona
authors.forename: Ahmad
authors.initials: A
authors.lastname: Aljada
authors.forename: Ajay
authors.initials: A
authors.lastname: Chaudhuri
authors.forename: Priya
authors.initials: P
authors.lastname: Mohanty
authors.forename: Rajesh
authors.initials: R
authors.lastname: Garg
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001161:Arteriosclerosis / Q000209:etiology / Q000503:physiopathology; D002097:C-Reactive Protein / Q000032:analysis; D016207:Cytokines / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology; D005502:Food / Q000009:adverse effects; D005786:Gene Expression Regulation; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000503:physiopathology; D006946:Hyperinsulinism / Q000150:complications / Q000503:physiopathology; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D015228:Hypertriglyceridemia / Q000150:complications / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007249:Inflammation / Q000150:complications / Q000235:genetics / Q000503:physiopathology; D007328:Insulin / Q000494:pharmacology / Q000502:physiology; D007333:Insulin Resistance; D008075:Lipoproteins, HDL / Q000378:metabolism; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology*; D008954:Models, Biological; D016328:NF-kappa B / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000503:physiopathology; D018384:Oxidative Stress; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D051381:Rats
chemical_list: D016207:Cytokines; D007004:Hypoglycemic Agents; D007328:Insulin; D008075:Lipoproteins, HDL; D016328:NF-kappa B; D017395:Plasminogen Activator Inhibitor 1; D002097:C-Reactive Protein